Analystreport

Adaptive Biotechnologies (NASDAQ:ADPT) is now covered by analysts at Guggenheim. They set a "buy" rating and a $20.00 price target on the stock.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com